Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine

Archives of Dermatology

Volumn 142, Issue 10, 2006, Pages 1337-1342

  McGirt, Laura Y ^a   Vasagar, Kavitha ^a   Gober, Laura M ^a   Saini, Sarbjit S ^a   Beck, Lisa A ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; CYPROHEPTADINE; DESLORATADINE; DIPHENHYDRAMINE; FEXOFENADINE; HYDROXYZINE; LORATADINE; PREDNISOLONE; PREDNISONE; SALAZOSULFAPYRIDINE; STEROID;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADOLESCENT; AGED; ARTICLE; CHRONIC URTICARIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DOSE RESPONSE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; IDIOPATHIC DISEASE; LEUKOPENIA; LIVER LEVEL; MALE; NAUSEA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; TRANSAMINITIS; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 33750049299     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.142.10.1337     Document Type: Article

References (51)

1. Swinney B. The atopic factor in urticaria. South Med J. 1941;34:855-858.
2. Sheldon JM, Mathews KP, Lovell RG. The vexing urticaria problem: present concepts of etiology and management. J Allergy. 1954;25:525-560.
3. Greaves MW. Chronic idiopathic urticaria. Curr Opin Allergy Clin Immunol. 2003;3:363-368.
4. Sibbald RG, Cheema AS, Lozinski A, Tarlo S. Chronic urticaria: evaluation of the role of physical, immunologic, and other contributory factors. Int J Dermatol. 1991;30:381-386.
5. Sabroe RA, Seed PT, Francis DM, Barr RM, Black AK, Greaves MW. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. J Am Acad Dermatol. 1999;40:443-450.
6. Champion RH, Roberts SO, Carpenter RG, Roger JH. Urticaria and angiooedema: a review of 554 patients. Br J Dermatol. 1969;81:588-597.
7. O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol. 1997;136:197-201.
8. Greaves MW. Chronic Idiopathic urticaria and H pylori: not directly causative but could there be a link? ACI Int. 2001;13:23-26.
9. Federman DG, Kirsner RS, Moriarty JP, Concato J. The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol. 2003;49:861-864.
10. Gaig P, Garcia-Ortega P, Enrique E, Papo M, Quer JC, Richard C. Efficacy of the eradication of Helicobacter pylori infection in patients with chronic urticaria: a placebo-controlled double blind study. Allergol Immunopathol (Madr). 2002;30:255-258.
11. Hook-Nikanne J, Varjonen E, Harvima RJ, Kosunen TU. Is Helicobacter pylori infection associated with chronic urticaria? Acta Derm Venereol. 2000;80:425-426.
12. Moreira A, Rodrigues J, Delgado L, Fonseca J, Vaz M. Is Helicobacter pylori infection associated with chronic idiopathic urticaria? Allergol Immunopathol (Madr). 2003;31:209-214.
13. Serrano H. Hypersensitivity to "Candida albicans" and other fungi in patients with chronic urticaria [in Spanish]. Allergol Immunopathol (Madr). 1975;3:289-298.
14. Tang XP, Zeng K, Chen GH, Bi LY, Fan LZ, Shao CF. Study of the association of Malassezia furfur with chronic urticaria among the ship crews [in Chinese]. Di Yi Jun Yi Da Xue Xue Bao. 2003;23:870-872.
15. Fiebiger E, Maurer D, Holub H, et al. Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients? J Clin Invest. 1995;96:2606-2612.
16. Tong LJ, Balakrishnan G, Kochan JP, Kinet JP, Kaplan AP. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol. 1997;99:461-465.
17. Zweiman B, Valenzano M, Atkins PC. Modulation of serum histamine releasing activity in chronic idiopathic urticaria. Immunopharmacology. 1998;39:225-234.
18. Niimi N, Francis DM, Kermani F, et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol. 1996;106:1001-1006.
19. Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med. 1993;328:1599-1604.
20. Grattan CE. Histamine-releasing autoantibodies in chronic urticaria. Skin Pharmacol. 1991;4(suppl 1):64-70.
21. Kandeel AA, Zeid M, Helm T, Lillie MA, Donahue E, Ambrus JL Jr. Evaluation of chronic urticaria in patients with Hashimoto thyroiditis. J Clin Immunol. 2001;21:335-347.
22. Turktas I, Gokcora N, Demirsoy S, Cakir N, Onal E. The association of chronic urticaria and angioedema with autoimmune thyroiditis. Int J Dermatol. 1997;36:187-190.
23. Zauli D, Grassi A, Ballardini G, Contestabile S, Zucchini S, Bianchi FB. Thyroid autoimmunity in chronic idiopathic urticaria: implications for therapy. Am J Clin Dermatol. 2002;3:525-528.
24. Leznoff A, Sussman GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol. 1989;84:66-71.
25. Kaplan AP. Chronic urticaria - new concepts regarding pathogenesis and treatment. Curr Allergy Asthma Rep. 2002;2:263-264.
26. Stanaland BE. Treatment of patients with chronic idiopathic urticaria. Clin Rev Allergy Immunol. 2002;23:233-241.
27. Kulthanan K, Gritiyarangsan P, Sitakalin C, et al. Multicenter study of the efficacy and safety of fexofenadine 60 mg twice daily in 108 Thai patients with chronic idiopathic urticaria. J Med Assoc Thai. 2001;84:153-159.
28. Vena GA, Cassano N, Filieri M, Filotico R, D'Argento V, Coviello C. Fexofenadine in chronic idiopathic urticaria: a clinical and immunohistochemical evaluation. Int J Immunopathol Pharmacol. 2002;15:217-224.
29. Sanada S, Tanaka T, Kameyoshi Y, Hide M. The effectiveness of montelukast for the treatment of anti-histamine-resistant chronic urticaria. Arch Dermatol Res. 2005;297:134-138.
30. Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol. 2004;114:465-475.
31. Grattan CE, O'Donnell BF, Francis DM, et al. Randomized double-blind study of cyclosporin in chronic "idiopathic" urticaria. Br J Dermatol. 2000;143:365-372.
32. Di Gioacchino M, Di Stefano F, Cavallucci E, et al. Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation. Allergy Asthma Proc. 2003;24:285-290.
33. Cassano N, D'Argento V, Filotico R, Vena GA. Low-dose dapsone in chronic idiopathic urticaria: preliminary results of an open study. Acta Derm Venereol. 2005;85:254-255.
34. Reeves GE, Boyle MJ, Bonfield J, Dobson P, Loewenthal M. Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. Intern Med J. 2004;34:182-186.
35. Gach JE, Sabroe RA, Greaves MW, Black AK. Methotrexate-responsive chronic idiopathic urticaria: a report of two cases. Br J Dermatol. 2001;145:340-343.
36. Weiner MJ. Methotrexate in corticosteroid-resistant urticaria. Ann Intern Med. 1989;110:848.
37. Bernstein JA, Garramone SM, Lower EG. Successful treatment of autoimmune chronic idiopathic urticaria with intravenous cyclophosphamide. Ann Allergy Asthma Immunol. 2002;89:212-214.
38. Jaffer AM. Sulfasalazine in the treatment of corticosteroid-dependent chronic idiopathic urticaria. J Allergy Clin Immunol. 1991;88:964-965.
39. Hartmann K, Hani N, Hinrichs R, Hunzelmann N, Scharffetter-Kochanek K. Successful sulfasalazine treatment of severe chronic idiopathic urticaria associated with pressure urticaria. Acta Derm Venereol. 2001;81:71.
40. Engler RJ, Squire E, Benson P. Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema. Ann Allergy Asthma Immunol. 1995;74:155-159.
41. Dougados M, Boumier P, Amor B. Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients. Br Med J (Clin Res Ed). 1986;293:911-914.
42. Willoughby CP, Cowan RE, Gould SR, Machell RJ, Stewart JB. Double-blind comparison of olsalazine and sulphasalazine in active ulcerative colitis. Scand J Gastroenterol Suppl. 1988;148:40-44.
43. Pinals RS, Kaplan SB, Lawson JG, Hepburn B. Sulfasalazine in rheumatoid arthritis: a double-blind, placebo-controlled trial. Arthritis Rheum. 1986;29:1427-1434.
44. Summers RW, Switz DM, Sessions JT Jr, et al. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology. 1979;77:847-869.
45. Gupta AK, Ellis CN, Siegel MT, et al. Sulfasalazine improves psoriasis: a double-blind analysis. Arch Dermatol. 1990;126:487-493.
46. Dougados M, vam der Linden S, Leirisalo-Repo M, et al. Sulfasalazine in the treatment of spondylarthropathy: a randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum. 1995;38:618-627.
47. Kozel MM, Sabroe RA. Chronic urticaria: aetiology, management and current and future treatment options. Drugs. 2004;64:2515-2536.
48. Vonakis BM, Saini SS. Basophils and mast cells in chronic idiopathic urticaria. Curr Allergy Asthma Rep. 2005;5:270-276.
49. Lee EH, Kim HM. Inhibition of anaphylaxis by sulfasalazine in rats. Pharmacology. 1998;56:223-229.
50. Fox CC, Moore WC, Lichtenstein LM. Modulation of mediator release from human intestinal mast cells by sulfasalazine and 5-aminosalicylic acid. Dig Dis Sci. 1991;36:179-184.
51. Barrett KE, Tashof TL, Metcalfe DD. Inhibition of IgE-mediated mast cell degranulation by sulphasalazine. Eur J Pharmacol. 1985;107:279-281.